pI: 7.5345 |
Length (AA): 516 |
MW (Da): 57645 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 507 | 2dpn (A) | 28 | 456 | 29.00 | 0 | 1 | 1.16606 | -0.06 |
1 | 515 | 2zf5 (O) | 29 | 464 | 25.00 | 0 | 1 | 1.12256 | -0.07 |
5 | 498 | 3ezw (A) | 34 | 451 | 29.00 | 0 | 1 | 1.16656 | -0.12 |
14 | 496 | 3g25 (A) | 42 | 448 | 29.00 | 0 | 1 | 1.12805 | -0.22 |
195 | 330 | 3gq8 (A) | 396 | 507 | 35.00 | 0.29 | 0.11 | 0.297566 | 0.67 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_126746)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G80460 | glycerol kinase |
Babesia bovis | BBOV_I004170 | glycerol kinase, putative |
Brugia malayi | Bm1_33005 | FGGY family of carbohydrate kinases, N-terminal domain containing protein |
Candida albicans | CaO19.558 | likely carbohydrate kinase similar to S. cerevisiae GUT1 (YHL032C) glycerol kinase |
Candida albicans | CaO19.8193 | likely carbohydrate kinase similar to S. cerevisiae GUT1 (YHL032C) glycerol kinase |
Caenorhabditis elegans | CELE_R11F4.1 | Protein R11F4.1 |
Caenorhabditis elegans | CELE_C55B6.1 | Protein C55B6.1, isoform B |
Dictyostelium discoideum | DDB_G0280371 | hypothetical protein |
Dictyostelium discoideum | DDB_G0278551 | hypothetical protein |
Drosophila melanogaster | Dmel_CG1271 | CG1271 gene product from transcript CG1271-RC |
Drosophila melanogaster | Dmel_CG7995 | Glycerol kinase |
Drosophila melanogaster | Dmel_CG18374 | Glycerol kinase |
Escherichia coli | b3926 | glycerol kinase |
Echinococcus granulosus | EgrG_000180000 | glycerol kinase |
Echinococcus granulosus | EgrG_000775900 | glycerol kinase 5 |
Entamoeba histolytica | EHI_164850 | glycerol kinase, putative |
Echinococcus multilocularis | EmuJ_000180000 | glycerol kinase |
Echinococcus multilocularis | EmuJ_000775900 | glycerol kinase 5 |
Giardia lamblia | GL50803_8173 | Glycerol kinase |
Homo sapiens | ENSG00000196475 | glycerol kinase 2 |
Homo sapiens | ENSG00000198814 | glycerol kinase |
Homo sapiens | ENSG00000175066 | glycerol kinase 5 (putative) |
Leishmania braziliensis | LbrM.34.2990 | glycerol kinase, glycosomal, putative |
Leishmania donovani | LdBPK_353130.1 | glycerol kinase, glycosomal, putative |
Leishmania infantum | LinJ.35.3130 | glycerol kinase, glycosomal, putative |
Leishmania major | LmjF.35.3080 | glycerol kinase, glycosomal, putative |
Leishmania mexicana | LmxM.34.3080 | glycerol kinase, glycosomal, putative |
Loa Loa (eye worm) | LOAG_11455 | hypothetical protein |
Loa Loa (eye worm) | LOAG_05489 | hypothetical protein |
Mycobacterium leprae | ML2314c | PROBABLE GLYCEROL KINASE GLPK (ATP:GLYCEROL 3-PHOSPHOTRANSFERASE)(GLYCEROKINASE) (GK) |
Mus musculus | ENSMUSG00000025059 | glycerol kinase |
Mus musculus | ENSMUSG00000050553 | glycerol kinase 2 |
Mus musculus | ENSMUSG00000053624 | glycerol kinase-like 1 |
Mus musculus | ENSMUSG00000041440 | glycerol kinase 5 (putative) |
Mycobacterium tuberculosis | Rv3696c | Probable glycerol kinase GlpK (ATP:glycerol 3-phosphotransferase) (glycerokinase) (GK) |
Mycobacterium ulcerans | MUL_4281 | glycerol kinase |
Oryza sativa | 4337206 | Os04g0647800 |
Onchocerca volvulus | OVOC2966 | Putative glycerol kinase 5 |
Onchocerca volvulus | OVOC11223 | Putative glycerol kinase |
Plasmodium berghei | PBANKA_1364300 | glycerol kinase, putative |
Plasmodium falciparum | PF3D7_1351600 | glycerol kinase |
Plasmodium knowlesi | PKNH_1249400 | glycerol kinase, putative |
Plasmodium vivax | PVX_083470 | glycerol kinase, putative |
Plasmodium yoelii | PY00935 | putative glycerol kinase |
Saccharomyces cerevisiae | YHL032C | glycerol kinase |
Schistosoma japonicum | Sjp_0060360 | ko:K00864 glycerol kinase [EC2.7.1.30], putative |
Schistosoma japonicum | Sjp_0054690 | ko:K00864 glycerol kinase [EC2.7.1.30], putative |
Schistosoma japonicum | Sjp_0308260 | Putative glycerol kinase 5, putative |
Schistosoma japonicum | Sjp_0093890 | Glycerol kinase, putative |
Schistosoma mansoni | Smp_124440 | glycerol kinase |
Schistosoma mansoni | Smp_141770 | glycerol kinase |
Schmidtea mediterranea | mk4.001024.05 | Putative glycerol kinase 5 |
Schmidtea mediterranea | mk4.009692.00 | Probable glycerol kinase |
Schmidtea mediterranea | mk4.050118.00 | |
Schmidtea mediterranea | mk4.005092.03 | Probable glycerol kinase |
Schmidtea mediterranea | mk4.002372.04 | Probable glycerol kinase |
Schmidtea mediterranea | mk4.025148.04 | |
Schmidtea mediterranea | mk4.002508.00 | Probable glycerol kinase |
Trypanosoma brucei gambiense | Tbg972.9.7700 | glycerol kinase, glycosomal |
Trypanosoma brucei gambiense | Tbg972.9.7710 | glycerol kinase, glycosomal |
Trypanosoma brucei | Tb927.9.12610 | glycerol kinase, glycosomal |
Trypanosoma brucei | Tb927.9.12550 | glycerol kinase, glycosomal |
Trypanosoma brucei | Tb927.9.12590 | glycerol kinase, glycosomal |
Trypanosoma brucei | Tb427tmp.211.3570 | glycerol kinase, glycosomal |
Trypanosoma brucei | Tb927.9.12570 | glycerol kinase, glycosomal |
Trypanosoma congolense | TcIL3000_0_55170 | glycerol kinase, glycosomal |
Trypanosoma cruzi | TcCLB.510661.60 | glycerol kinase, glycosomal, putative |
Theileria parva | TP02_0725 | glycerol kinase, putative |
Trichomonas vaginalis | TVAG_353000 | xylulose kinase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.211.3540 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb09.211.3540 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb09.211.3540 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb09.211.3540 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b3926 | Escherichia coli | non-essential | goodall |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.